87 related articles for article (PubMed ID: 23443752)
1. When direct health-care professional communications have an impact on inappropriate and unsafe use of medicines.
Reber KC; Piening S; Wieringa JE; Straus SM; Raine JM; de Graeff PA; Haaijer-Ruskamp FM; Mol PG
Clin Pharmacol Ther; 2013 Apr; 93(4):360-5. PubMed ID: 23443752
[TBL] [Abstract][Full Text] [Related]
2. A decade of safety-related regulatory action in the Netherlands: a retrospective analysis of direct healthcare professional communications from 1999 to 2009.
Mol PG; Straus SM; Piening S; de Vries JT; de Graeff PA; Haaijer-Ruskamp FM
Drug Saf; 2010 Jun; 33(6):463-74. PubMed ID: 20486729
[TBL] [Abstract][Full Text] [Related]
3. Impact of safety-related regulatory action on drug use in ambulatory care in the Netherlands.
Piening S; Reber KC; Wieringa JE; Straus SM; de Graeff PA; Haaijer-Ruskamp FM; Mol PG
Clin Pharmacol Ther; 2012 May; 91(5):838-45. PubMed ID: 22472991
[TBL] [Abstract][Full Text] [Related]
4. Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands.
de Vries E; Denig P; de Vries ST; Monster TBM; Hugtenburg JG; Mol PGM
Drug Saf; 2020 Jul; 43(7):677-690. PubMed ID: 32212054
[TBL] [Abstract][Full Text] [Related]
5. Dissemination of Direct Healthcare Professional Communications on Medication Errors for Medicinal Products in the EU: An Explorative Study on Relevant Factors.
Hoeve CE; de Vries E; Mol PGM; Sturkenboom MCJM; Straus SMJM
Drug Saf; 2021 Jan; 44(1):73-82. PubMed ID: 33355904
[TBL] [Abstract][Full Text] [Related]
6. Safety Communication Tools and Healthcare Professionals' Awareness of Specific Drug Safety Issues in Europe: A Survey Study.
de Vries ST; van der Sar MJM; Coleman AM; Escudero Y; Rodríguez Pascual A; Maciá Martínez MÁ; Cupelli A; Baldelli I; Šipić I; Andrić A; Michan L; Denig P; Mol PGM;
Drug Saf; 2018 Jul; 41(7):713-724. PubMed ID: 29500798
[TBL] [Abstract][Full Text] [Related]
7. Factors Influencing Preferences and Responses Towards Drug Safety Communications: A Conjoint Experiment Among Hospital-Based Healthcare Professionals in the Netherlands.
de Vries E; Bakker E; Monster TBM; Denig P; Mol PGM
Drug Saf; 2022 Nov; 45(11):1369-1380. PubMed ID: 36107383
[TBL] [Abstract][Full Text] [Related]
8. Healthcare professionals' self-reported experiences and preferences related to direct healthcare professional communications: a survey conducted in the Netherlands.
Piening S; Haaijer-Ruskamp FM; de Graeff PA; Straus SM; Mol PG
Drug Saf; 2012 Nov; 35(11):1061-72. PubMed ID: 23061782
[TBL] [Abstract][Full Text] [Related]
9. Inappropriate medication prescribing for elderly ambulatory care patients.
Goulding MR
Arch Intern Med; 2004 Feb; 164(3):305-12. PubMed ID: 14769626
[TBL] [Abstract][Full Text] [Related]
10. The Additional Value of an E-Mail to Inform Healthcare Professionals of a Drug Safety Issue: A Randomized Controlled Trial in the Netherlands.
Piening S; de Graeff PA; Straus SM; Haaijer-Ruskamp FM; Mol PG
Drug Saf; 2013 Sep; 36(9):723-31. PubMed ID: 23797603
[TBL] [Abstract][Full Text] [Related]
11. The impact of direct healthcare professional communication on prescribing practice in the UK hospital setting: an interrupted time series analysis.
Thomas SK; Hodson J; McIlroy G; Dhami A; Coleman JJ
Drug Saf; 2013 Jul; 36(7):557-64. PubMed ID: 23657825
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
[TBL] [Abstract][Full Text] [Related]
13. Effect of safety issues with HIV drugs on the approval process of other drugs in the same class: an analysis of European Public Assessment Reports.
Arnardottir AH; Haaijer-Ruskamp FM; Straus SM; de Graeff PA; Mol PG
Drug Saf; 2011 Nov; 34(11):1101-14. PubMed ID: 21981437
[TBL] [Abstract][Full Text] [Related]
14. If you don't know where you are going, you can't tell if you have arrived: defining goals for drug safety announcements.
Wood AJ
Clin Pharmacol Ther; 2013 Apr; 93(4):302-3. PubMed ID: 23511785
[TBL] [Abstract][Full Text] [Related]
15. Are monitoring instructions provided in direct healthcare professional communications (DHPCs) of sufficient quality? A retrospective analysis of DHPCs sent out between 2007 and 2018.
Højer MG; De Bruin ML; Boskovic A; Hallgreen CE
BMJ Open; 2020 May; 10(5):e036498. PubMed ID: 32398337
[TBL] [Abstract][Full Text] [Related]
16. Inconsistencies among European Union pharmaceutical regulator safety communications: a cross-country comparison.
Zeitoun JD; Lefèvre JH; Downing N; Bergeron H; Ross JS
PLoS One; 2014; 9(10):e109100. PubMed ID: 25333986
[TBL] [Abstract][Full Text] [Related]
17. [The increase in the use of drug treatment for diabetes mellitus in the Netherlands, 1998-2003].
Langendam MW; Hooijkaas C; Piepenbrink JF
Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1396-401. PubMed ID: 16841589
[TBL] [Abstract][Full Text] [Related]
18. [Integrated care. Taking a stand].
Schalkhäuser K
Urologe A; 2005 May; 44(5):473-6. PubMed ID: 15827709
[No Abstract] [Full Text] [Related]
19. Why do general practitioners disregard direct to healthcare professional communication? A user-oriented evaluation to improve drug safety communication.
Møllebaek M; Kaae S
Basic Clin Pharmacol Toxicol; 2021 Mar; 128(3):463-471. PubMed ID: 33043558
[TBL] [Abstract][Full Text] [Related]
20. Analgesic prescribing for musculoskeletal complaints in the ambulatory care setting after the introduction and withdrawal of cyclooxygenase-2 inhibitors.
Wilson RD
Arch Phys Med Rehabil; 2009 Jul; 90(7):1147-51. PubMed ID: 19577028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
